IRVINE, Calif., Oct. 28, 2013 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and cancer diagnostics, today reported summary selected preliminary unaudited third quarter financial results. The Company is currently in the process of finalizing its unaudited consolidated financial statements for the three months ended September 30, 2013, and therefore, the complete financial results are not yet available.
Help employers find you! Check out all the jobs and post your resume.
